N@N

BioScrip, Inc. to Present at Two Upcoming Conferences

^{Published on 2010-05-26 14:15:15 - Market Wire}
 

ELMSFORD, N.Y.--([ BUSINESS WIRE ])--BioScrip, Inc. (Nasdaq: BIOS) today announced that the Company will present at two upcoming conferences.

• On June 7, 2010, Richard H. Friedman, BioScripa™s Chairman and Chief Executive Officer, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer, will present at the Noble Financial Sixth Annual Equity Conference at 11:00 AM Eastern Daylight Time (EDT) at the Hard Rock Hotel in Hollywood, Florida. A live audio webcast of the event may be accessed at [ www.ontrack10.com ] or [ www.nobleresearch.com ].
• On June 8, 2010, Richard H. Friedman, Stanley G. Rosenbaum, and Richard M. Smith, President and Chief Operating Officer, will present at the Jefferies 2010 Global Life Sciences Conference at 11:30 AM EDT at the Grand Hyatt in New York City. A live audio webcast of the event may be accessed at [ http://www.wsw.com/webcast/jeff46/bios/ ].

A replay of each presentation will be available through BioScripa™s website at [ www.bioscrip.com ] under the aInvestor Relationsa section and will remain available through Tuesday, June 22, 2010.

About BioScrip, Inc.

BioScrip, Inc. ([ www.bioscrip.com ]) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payers and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions.

Forward Looking Statements-Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.